Molina Healthcare price target lowered to $190 from $218 at BofA

BofA lowered the firm’s price target on Molina Healthcare (MOH) to $190 from $218 and keeps an Underperform rating on the shares. The Q2 report was below expectations and the company once again lowered guidance coming off of updated guidance earlier in the month, the analyst noted. All segments came in worse than expectations, echoing the higher utilization commentary from peers, adds the analyst, who cites medical loss ratio pressure and heightened uncertainty on 2026 EPS for the firm’s Underperform rating.